Annual CFF
$608.85 M
+$604.66 M+14424.12%
December 31, 2024
Summary
- As of March 10, 2025, KYMR annual cash flow from financing activities is $608.85 million, with the most recent change of +$604.66 million (+14424.12%) on December 31, 2024.
- During the last 3 years, KYMR annual CFF has risen by +$358.57 million (+143.27%).
- KYMR annual CFF is now at all-time high.
Performance
KYMR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.77 M
-$248.15 M-98.90%
December 31, 2024
Summary
- As of March 10, 2025, KYMR quarterly cash flow from financing activities is $2.77 million, with the most recent change of -$248.15 million (-98.90%) on December 31, 2024.
- Over the past year, KYMR quarterly CFF has increased by +$831.00 thousand (+42.97%).
- KYMR quarterly CFF is now -99.22% below its all-time high of $353.76 million, reached on March 31, 2024.
Performance
KYMR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$608.85 M
+$831.00 K+0.14%
December 31, 2024
Summary
- As of March 10, 2025, KYMR TTM cash flow from financing activities is $608.85 million, with the most recent change of +$831.00 thousand (+0.14%) on December 31, 2024.
- Over the past year, KYMR TTM CFF has increased by +$604.66 million (+14424.12%).
- KYMR TTM CFF is now at all-time high.
Performance
KYMR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KYMR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +43.0% | +10000.0% |
| 3 y3 years | +143.3% | +43.0% | +10000.0% |
| 5 y5 years | +1644.0% | +43.0% | +10000.0% |
KYMR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -99.2% | +1442.2% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -99.2% | +786.1% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -99.2% | +786.1% | at high | >+9999.0% |
Kymera Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $608.85 M(>+9900.0%) | $2.77 M(-98.9%) | $608.85 M(+0.1%) |
| Sep 2024 | - | $250.92 M(>+9900.0%) | $608.02 M(+70.4%) |
| Jun 2024 | - | $1.41 M(-99.6%) | $356.90 M(+0.0%) |
| Mar 2024 | - | $353.76 M(>+9900.0%) | $356.79 M(+8411.2%) |
| Dec 2023 | $4.19 M(-97.3%) | $1.93 M(-1038.8%) | $4.19 M(-0.5%) |
| Sep 2023 | - | -$206.00 K(-115.8%) | $4.21 M(-97.3%) |
| Jun 2023 | - | $1.30 M(+12.6%) | $154.91 M(+0.6%) |
| Mar 2023 | - | $1.16 M(-40.7%) | $153.97 M(+0.6%) |
| Dec 2022 | $153.00 M | $1.95 M(-98.7%) | $153.00 M(-0.1%) |
| Sep 2022 | - | $150.50 M(>+9900.0%) | $153.10 M(-38.4%) |
| Jun 2022 | - | $364.00 K(+96.8%) | $248.64 M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $185.00 K(-91.0%) | $249.87 M(-0.2%) |
| Dec 2021 | $250.28 M(-13.5%) | $2.05 M(-99.2%) | $250.28 M(+0.7%) |
| Sep 2021 | - | $246.04 M(>+9900.0%) | $248.50 M(+25.0%) |
| Jun 2021 | - | $1.59 M(+167.6%) | $198.73 M(+1.0%) |
| Mar 2021 | - | $595.00 K(+120.4%) | $196.74 M(-32.0%) |
| Dec 2020 | $289.26 M(+728.6%) | $270.00 K(-99.9%) | $289.26 M(+0.1%) |
| Sep 2020 | - | $196.28 M(<-9900.0%) | $288.99 M(+211.7%) |
| Jun 2020 | - | -$403.00 K(-100.4%) | $92.72 M(-0.4%) |
| Mar 2020 | - | $93.12 M | $93.12 M |
| Dec 2019 | $34.91 M(-34.0%) | - | - |
| Dec 2018 | $52.93 M | - | - |
FAQ
- What is Kymera Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Kymera Therapeutics?
- What is Kymera Therapeutics annual CFF year-on-year change?
- What is Kymera Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly CFF year-on-year change?
- What is Kymera Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kymera Therapeutics?
- What is Kymera Therapeutics TTM CFF year-on-year change?
What is Kymera Therapeutics annual cash flow from financing activities?
The current annual CFF of KYMR is $608.85 M
What is the all time high annual CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash flow from financing activities is $608.85 M
What is Kymera Therapeutics annual CFF year-on-year change?
Over the past year, KYMR annual cash flow from financing activities has changed by +$604.66 M (+14424.12%)
What is Kymera Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of KYMR is $2.77 M
What is the all time high quarterly CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash flow from financing activities is $353.76 M
What is Kymera Therapeutics quarterly CFF year-on-year change?
Over the past year, KYMR quarterly cash flow from financing activities has changed by +$831.00 K (+42.97%)
What is Kymera Therapeutics TTM cash flow from financing activities?
The current TTM CFF of KYMR is $608.85 M
What is the all time high TTM CFF for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM cash flow from financing activities is $608.85 M
What is Kymera Therapeutics TTM CFF year-on-year change?
Over the past year, KYMR TTM cash flow from financing activities has changed by +$604.66 M (+14424.12%)